Phenotyping & /or Genotyping [Regulatives / Guidelines]

posted by joyjac – Philippines, 2006-06-16 04:30 (7318 d 04:58 ago) – Posting: # 152
Views: 8,674

Do you consider phenotyping &/or genotyping in a single-dose 2-way cross-over bioequivalence study, particularly for drugs that undergo oxidative metabolism e.g. metoprolol, to reduce inter-subject variability? Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
391 visitors (0 registered, 391 guests [including 19 identified bots]).
Forum time: 09:29 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5